Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial [see comments]

M Cazzola, L Ponchio, Y Beguin, V Rosti, G Bergamaschi, NL Liberato, V Fregoni, G Nalli, G Barosi, E Ascari

Blood (1992) 79 (1): 29–37.

https://doi.org/10.1182/blood.V79.1.29.29

Published: 1992

Journal Articles

Isolation of Reed-Sternberg cells from lymph nodes of Hodgkin's disease patients

G Sitar, E Brusamolino, C Bernasconi, E Ascari

Blood (1989) 73 (1): 222–229.

https://doi.org/10.1182/blood.V73.1.222.222

Published: 1989

Journal Articles

Synergistic antiproliferative effect of recombinant interferon-gamma with recombinant interferon-alpha on chronic myelogenous leukemia hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM)

C Carlo-Stella, M Cazzola, A Ganser, G Bergamaschi, P Pedrazzoli, D Hoelzer, E Ascari

Blood (1988) 72 (4): 1293–1299.

https://doi.org/10.1182/blood.V72.4.1293.1293

Published: 1988

Journal Articles

Natural history of idiopathic refractory sideroblastic anemia

M Cazzola, G Barosi, PG Gobbi, R Invernizzi, A Riccardi, E Ascari

Blood (1988) 71 (2): 305–312.

https://doi.org/10.1182/blood.V71.2.305.305

Published: 1988

Journal Articles

Effects of recombinant alpha and gamma interferons on the in vitro growth of circulating hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM) from patients with myelofibrosis with myeloid metaplasia

C Carlo-Stella, M Cazzola, A Gasner, G Barosi, L Dezza, F Meloni, P Pedrazzoli, D Hoelzer, E Ascari

Blood (1987) 70 (4): 1014–1019.

https://doi.org/10.1182/blood.V70.4.1014.1014

Published: 1987

Journal Articles

Biologic and clinical significance of red cell ferritin

M Cazzola, L Dezza, G Bergamaschi, G Barosi, V Bellotti, D Caldera, MM Ciriello, S Quaglini, P Arosio, E Ascari

Blood (1983) 62 (5): 1078–1087.

https://doi.org/10.1182/blood.V62.5.1078.1078

Published: 1983

NARROW

Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial [see comments]

Isolation of Reed-Sternberg cells from lymph nodes of Hodgkin's disease patients

Synergistic antiproliferative effect of recombinant interferon-gamma with recombinant interferon-alpha on chronic myelogenous leukemia hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM)

Natural history of idiopathic refractory sideroblastic anemia

Effects of recombinant alpha and gamma interferons on the in vitro growth of circulating hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM) from patients with myelofibrosis with myeloid metaplasia

Biologic and clinical significance of red cell ferritin

Email alerts

ASH Publications

American Society of Hematology

Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial [see comments]

Isolation of Reed-Sternberg cells from lymph nodes of Hodgkin's disease patients

Synergistic antiproliferative effect of recombinant interferon-gamma with recombinant interferon-alpha on chronic myelogenous leukemia hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM)

Natural history of idiopathic refractory sideroblastic anemia

Effects of recombinant alpha and gamma interferons on the in vitro growth of circulating hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM) from patients with myelofibrosis with myeloid metaplasia

Biologic and clinical significance of red cell ferritin

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only